Only available to extend active Alzheimer’s Research UK Major grants.
The lead applicant and point of contact must be based in a UK academic/research institution. However, the application can include researchers or institutions outside the UK
Only one extension grant will be permitted per Alzheimer’s Research UK Major grant.
The lead applicant must be the named grant holder for the Alzheimer’s Research UK Major grant to be extended.
The lead applicant is expected to have a contract (fixed term or tenure) which covers the proposed duration of the grant. If the Lead Applicant does not hold a tenure appointment, the application must include a co-applicant that does.
If the project requires ethical approval and/or Home Office licences, the award is dependent upon the requisite approvals being granted.
This scheme is not designed to cover:
- Clinical trials and opportunities to research ‘add ons’ to ongoing clinical trials
- Drug discovery or development
Clinical trials and add-ons should be applied for through the Global Clinical Trials Fund. Drug discovery and development work should be applied for through the Dementia Consortium or through ARUK’s Drug Discovery Institutes.
Applications are made via our grant application website.
Grant schemes only appear on this website when the round is open and we are accepting new applications.
Alzheimer’s Research UK is a member of the Association of Medical Research Charities and follows their guidelines for best practice in peer review. Grants are awarded entirely on scientific merit in relation to ARUK’s remit and on the basis of open competition. The quality of the application and applicants is the key determinant of outcome, although the strength of the dementia research environment within the institution is also considered.
Applications requesting funding of over £50,000 per year are subjected to external peer review. Applications are sent to researchers in the UK and worldwide who specialise in the area of the application, but who do not have a conflict of interest and are not a member of the Grant Review Board (GRB). The comments made by the external reviewers are made available to the GRB members. The external reviews and rebuttals will be discussed at a GRB meeting alongside the other Major grant applications in that round.
Applications for research studies that involve people require lay review. Applicants are requested to complete a lay summary of their application which is sent to lay review volunteers for comments. The comments made by lay reviewers are made available to the GRB members.
Discussion in meeting
If the application is for less than £50,000 it will go straight to the GAP meeting.
Each application is allocated to two GRB members, based roughly on their areas of expertise. The two members will present the application to the rest of the panel, including any relevant information from external reviews or applicant responses. A short discussion will follow before the GRB score the application. Applications for each grant scheme are ranked by their average score and recommendations for funding are made.
Those applications recommended for funding by the GRB are presented to the trustees for final approval.
The terms and conditions of grant differ for each grant scheme and contracts are drawn up individually once the grants have been awarded.
Our Grant Review Board (GRB) members are asked to read a subset of applications related to their area of expertise and provide a score based on whether an application should proceed to the next stage of review.
In the last three years Alzheimer’s Research UK has received four applications of Extension grants. One of these projects was awarded funding.
The terms and conditions of grant differ for each grant and contracts are drawn up individually once the grants have been awarded.
All grant holders are expected to report on the progress of their project on a regular basis. Read more about our reporting requirements on the measuring impact page.
For more information about any of the grant schemes or the application process please contact the Research Team email@example.com or 0300 111 5555